Mesothelioma
Showing 1 - 25 of 726
Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Mesothelioma
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 1, 2023
Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)
Not yet recruiting
- Pleural Mesothelioma
- Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
-
Rozzano, MI, Italy
- +5 more
Nov 30, 2023
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in
Recruiting
- Malignant Pleural Mesothelioma, Advanced
- Oncolytic Adenovirus H101
- Programmed death receptor-1 inhibitor
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Sep 2, 2023
Patients With Mesothelioma
Not yet recruiting
- Mesothelioma
- (no location specified)
Apr 21, 2023
Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)
Not yet recruiting
- Pleural Mesothelioma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 3, 2023
Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,
Recruiting
- Malignant Peritoneal Mesothelioma
- +4 more
- Pemetrexed
- +2 more
-
Chicago, Illinois
- +10 more
Sep 21, 2023
Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus
Not yet recruiting
- Mesothelioma
- Durvalumab / tremelimumab
- Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
-
Durham, North Carolina
- +1 more
Jul 5, 2023
Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)
Active, not recruiting
- Malignant Pleural Mesothelioma
- Mesothelioma
- Cisplatin
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023
Malignant Pleural Mesothelioma Trial (Proton beam therapy)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Proton beam therapy
- (no location specified)
Dec 14, 2022
Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)
Recruiting
- Malignant Pleural Mesothelioma
- E-Nose testing
- Research blood
-
Basking Ridge, New Jersey
- +6 more
Sep 8, 2023
Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Gemcitabine
- supportive care
-
Cairo, EgyptAin Shams University Hospital
Dec 20, 2022
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023
Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)
Active, not recruiting
- Cancer
- +6 more
- UV1 vaccine + leukine
- +2 more
-
Perth, Australia
- +6 more
Jan 23, 2023
Mesothelioma Patients and Their Family Members With Germline
Recruiting
- Mesothelioma
- Families
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)
Recruiting
- Mesotheliomas Pleural
-
Amsterdam, Noord-Holland, NetherlandsAntoni van Leeuwenhoekziekenhuis (NKI-AVL)
Jan 13, 2023
Mesothelioma Trial (Magnesium sulfate, Normal Saline)
Not yet recruiting
- Mesothelioma
- Magnesium sulfate
- Normal Saline
- (no location specified)
Feb 15, 2023
Pleural Mesothelioma Trial in Rochester (Immunotherapy, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy)
Recruiting
- Pleural Mesothelioma
- Immunotherapy
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))
Completed
- Pleural Mesothelioma
- Cyclophosphamide
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)
Not yet recruiting
- Pleural Biphasic Mesothelioma
- Pleural Sarcomatoid Mesothelioma
- Nivolumab
- +5 more
- (no location specified)
Dec 9, 2022
Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived
Not yet recruiting
- Advanced Renal Cell Carcinoma
- +2 more
- CAR.70/IL15-transduced CB-derived NK cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
TTFields in General Routine Clinical Care in Pleural
Not yet recruiting
- Pleural Mesothelioma
- TTFields
- (no location specified)
Sep 9, 2022
NSCLC, Mesothelioma, Thymoma Trial in Breda, Dordrecht (Folinic acid)
Recruiting
- NSCLC
- +2 more
- Folinic acid
-
Breda, Noord Brabant, Netherlands
- +1 more
Aug 17, 2023
Peritoneal Carcinomatosis, Peritoneal Mesothelioma, Ovarian Cancer Trial run by the NCI (Mitomycin C, Cisplatin, Heated
Recruiting
- Peritoneal Carcinomatosis
- +4 more
- Mitomycin C
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)
Active, not recruiting
- Mesothelioma
- +2 more
- Galinpepimut-S
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 23, 2022
Mesothelioma; Lung Trial in Toronto (Varying Doses of Background and Boost RT)
Active, not recruiting
- Mesothelioma; Lung
- Varying Doses of Background and Boost RT
-
Toronto, Ontario, CanadaPrincess Margaret Hospital, University Health Network
Oct 25, 2022